Bruker (NASDAQ:BRKR) Shares Up 3.6% – Should You Buy?

Bruker Corporation (NASDAQ:BRKR) shares rose 3.6% during trading on Thursday . The company traded as high as $60.82 and last traded at $61.8050. 70,144 shares changed hands during trading, a decline of 97% from the average session volume of 2,355,954 shares. The stock had previously closed at $59.67.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on BRKR shares. Zacks Research lowered Bruker from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, September 2nd. Stifel Nicolaus set a $50.00 target price on Bruker in a research note on Wednesday, August 5th. Leerink Partners lifted their target price on Bruker from $60.00 to $70.00 and gave the stock an “outperform” rating in a research report on Tuesday, July 7th. Barclays upped their price target on shares of Bruker from $53.00 to $60.00 and gave the stock an “overweight” rating in a report on Wednesday, June 24th. Finally, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Bruker in a research note on Monday, August 31st. Two analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Bruker has an average rating of “Moderate Buy” and a consensus price target of $57.00.

Bruker Stock Performance

The firm has a 50 day moving average of $58.27 and a 200-day moving average of $50.44. The company has a market cap of $9.27 billion, a P/E ratio of -87.04, a PEG ratio of 1.87 and a beta of 1.26. The company has a quick ratio of 0.92, a current ratio of 1.85 and a debt-to-equity ratio of 0.76.

Bruker (NASDAQ:BRKR) last issued its earnings results on Tuesday, August 4th. The medical research company reported $0.49 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.11. Bruker had a positive return on equity of 12.47% and a negative net margin of 2.35%.The business had revenue of $838.50 million during the quarter, compared to analysts’ expectations of $853.57 million. During the same period in the prior year, the business earned $0.32 EPS. The business’s revenue for the quarter was up 5.2% compared to the same quarter last year. Bruker has set its FY 2026 guidance at 2.100-2.150 EPS. As a group, sell-side analysts anticipate that Bruker Corporation will post 2.12 EPS for the current fiscal year.

Bruker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 7th. Shareholders of record on Monday, September 21st will be issued a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date is Monday, September 21st. Bruker’s dividend payout ratio is presently -28.57%.

Insider Activity at Bruker

In other news, VP Mark Munch sold 2,000 shares of the business’s stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $52.87, for a total value of $105,740.00. Following the completion of the sale, the vice president owned 134,806 shares in the company, valued at approximately $7,127,193.22. The trade was a 1.46% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 27.20% of the company’s stock.

Hedge Funds Weigh In On Bruker

Hedge funds and other institutional investors have recently modified their holdings of the business. Sequoia Financial Advisors LLC purchased a new stake in Bruker during the second quarter worth $250,000. Tidal Investments LLC increased its holdings in shares of Bruker by 180.4% in the 2nd quarter. Tidal Investments LLC now owns 29,092 shares of the medical research company’s stock valued at $1,751,000 after acquiring an additional 18,715 shares during the period. WINTON GROUP Ltd bought a new position in shares of Bruker in the 2nd quarter worth $344,000. Engineers Gate Manager LP raised its position in shares of Bruker by 141.8% in the 2nd quarter. Engineers Gate Manager LP now owns 56,825 shares of the medical research company’s stock worth $3,420,000 after acquiring an additional 33,329 shares in the last quarter. Finally, Integrated Wealth Concepts LLC purchased a new stake in shares of Bruker during the 2nd quarter worth $445,000. 79.52% of the stock is currently owned by institutional investors.

About Bruker

Bruker Corporation develops and manufactures scientific instruments, analytical systems and software used to study the chemical, physical and biological properties of materials. Its customers include universities, pharmaceutical and biotechnology companies, industrial manufacturers, hospitals, government laboratories and other research organizations.

The company’s product portfolio includes nuclear magnetic resonance and electron paramagnetic resonance systems, mass spectrometers, X-ray analysis instruments, optical and molecular spectroscopy systems, microscopy and nanoanalysis tools, and instruments for microbiology and spatial biology.